EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 3.0

Survival of Children with Acute Lymphoblastic Leukemia with Risk Group–Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period

Na Hee Lee, Hee Young Ju, Eun Sang Yi, Young Bae Choi, Keon Hee Yoo, Hong Hoe Koo

Cancer Research and Treatment · 2025

DOI: 10.4143/crt.2024.127 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Na Hee Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Cha Bundang Medical Center, Cha University, Seongnam, Korea. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Recent treatments for pediatric acute lymphoblastic leukemia (ALL) are founded on risk stratification. We examined the survival rates and prognostic factors of patients over a 20-year period at a single institution.Materials and Methods This study analyzed patients diagnosed with ALL and treated at the Pediatric Department of Samsung Medical Center (SMC). Patients were categorized into standard-risk (SR), high-risk (HR), and very high-risk (VHR) groups. The SMC protocol for the HR group underwent two changes during the study period: a modified Children’s Cancer Group (CCG)-1882 protocol was used from 2000 to 2005, the Korean multicenter HR ALL-0601 protocol from 2006 to 2014, and the Korean multicenter HR ALL-1501 protocol from 2015 to 2019.

Results

Of the 460 patients, complete remission was achieved in 436 patients (94.8%). The 10-year overall survival rate (OS) was 83.8±1.9% for all patients. OS according to the SMC risk group was as follows: 95.9%±1.4% in the SR group, 83.8%±3.6% in the HR group, and 66.2%±6.9% in the VHR group. The 5-year OS within the HR group varied according to the treatment protocol: 73.9%±7.5%, in the modified CCG-1882 protocol, 83.0%±3.9%, in the 0601 protocol, and 96.2%±2.6%, in the 1501 protocol. For those aged 15 years and older, the OS was only 56.5%±13.1%. Relapse occurred in 71 patients (15.4%), and the OS after relapse was 37.7%±6.0%.

Conclusion

The treatment outcomes of patients with ALL improved markedly. However, there is a need to further characterize adolescents and young adult patients, as well as those who have experienced relapses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleChildChild, PreschoolAdolescentPrognosisInfantSurvival RateRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaPediatricsPrognosisRisk factors

Autor:innen und Institutionen

  • Department of Pediatrics, Cha Bundang Medical Center, Cha University, Seongnam, Korea.
  • Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea.
  • Korea Hemophilia Foundation, Seoul, Korea.

Zitieren

APA

Lee, N. H., Ju, H. Y., Yi, E. S., Choi, Y. B., Yoo, K. H., & Koo, H. H. (2025). Survival of Children with Acute Lymphoblastic Leukemia with Risk Group–Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.127

Vancouver

Lee NH, Ju HY, Yi ES, Choi YB, Yoo KH, Koo HH. Survival of Children with Acute Lymphoblastic Leukemia with Risk Group–Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period. Cancer Research and Treatment. 2025. doi:10.4143/crt.2024.127

BibTeX
@article{Lee2025,
  author = {Lee, Na Hee and Ju, Hee Young and Yi, Eun Sang and Choi, Young Bae and Yoo, Keon Hee and Koo, Hong Hoe},
  title = {Survival of Children with Acute Lymphoblastic Leukemia with Risk Group–Based Protocol Changes: A Single-Center Experience with 460 Patients over a 20-Year Period},
  journal = {Cancer Research and Treatment},
  year = {2025},
  doi = {10.4143/crt.2024.127}
}
Kostenlos starten →